EUROPE NASAL SPRAY MARKET 2021-2028

 

 TABLE OF CONTENTS

 

1.     EUROPE NASAL SPRAY MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET

2.2. KEY INSIGHTS

2.2.1.    ALLERGY TREATMENTS WITH NASAL SPRAYS

2.2.2.    UTILIZING NASAL SPRAY FOR DIABETES

2.2.3.    ENDOMETRIOSIS TREATMENT WITH NASAL SPRAYS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    CONTRACTS & AGREEMENTS

2.6.3.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    EMERGING INTRANASAL VACCINES FOR COVID-19

2.7.2.    INCREASING ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION

2.7.3.    GROWING USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES

2.8. MARKET CHALLENGES

2.8.1.    COMPLICATIONS DUE TO EXCESS USE OF NASAL SPRAYS

2.9. MARKET OPPORTUNITIES

2.9.1.    APPLICATION OF NASAL SPRAYS IN TREATING DEPRESSION

2.9.2.    USING INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS

2.9.3.    EMPLOYING NASAL SPRAY AS A VACCINE

3.     EUROPE NASAL SPRAY MARKET OUTLOOK - BY TYPE

3.1. DECONGESTION NASAL SPRAY

3.2. STEROID NASAL SPRAY

3.3. SALTWATER SOLUTION/SALINE NASAL SPRAY

4.     EUROPE NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION

4.1. OVER-THE-COUNTER

4.2. PRESCRIBED

5.     EUROPE NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC

5.1. ANTIHISTAMINE

5.2. NASAL STEROIDS

5.3. ANTICHOLINERGIC

5.4. MAST CELL INHIBITOR

6.     EUROPE NASAL SPRAY MARKET OUTLOOK - BY APPLICATION

6.1. NASAL CONGESTION

6.2. ALLERGIC AND NON-ALLERGIC RHINITIS

6.3. VACCINATION

6.4. CNS DISORDERS

6.5. OTHER APPLICATIONS

7.     EUROPE NASAL SPRAY MARKET OUTLOOK - BY END-USER

7.1. HOME CARE SETTING

7.2. ASC/CLINICS

7.3. PHARMACY

7.4. HOSPITAL

7.5. OTHER END-USERS

8.     EUROPE NASAL SPRAY MARKET – REGIONAL OUTLOOK

8.1. UNITED KINGDOM

8.2. GERMANY

8.3. FRANCE

8.4. SPAIN

8.5. ITALY

8.6. RUSSIA

8.7. REST OF EUROPE

9.     COMPETITIVE LANDSCAPE

9.1. AKORN

9.2. ALLERGAN

9.3. APOTEX INC

9.4. BHARAT BIOTECH

9.5. CATALENT INC

9.6. CIPLA LIMITED

9.7. GLAXOSMITHKLINE

9.8. JOHNSON AND JOHNSON

9.9. NOVARTIS INTERNATIONAL AG

9.10.               PFIZER INC

9.11.               PROCTOR AND GAMBLE CO

9.12.               SANOTIZE RESEARCH AND DEVELOPMENT

9.13.               SUN PHARMACEUTICALS INDUSTRIES LTD

9.14.               TEVA PHARMACEUTICAL INDUSTRIES LTD

9.15.               VIATRIS

10. RESEARCH METHODOLOGY & SCOPE

10.1.               RESEARCH SCOPE & DELIVERABLES

10.2.               SOURCES OF DATA

10.3.               RESEARCH METHODOLOGY

 

 

TABLE LIST

TABLE 1: EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: EUROPE NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 4: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 5: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: EUROPE NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

 

 

FIGURE LIST

 

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: EUROPE NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: EUROPE NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 4: EUROPE NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 5: EUROPE NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 6: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)

FIGURE 7: EUROPE NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)

FIGURE 10: EUROPE NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 15: EUROPE NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 20: EUROPE NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 21: EUROPE NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 22: EUROPE NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 23: EUROPE NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 25: EUROPE NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: EUROPE NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: UNITED KINGDOM NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: GERMANY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: FRANCE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: SPAIN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: ITALY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: RUSSIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 33: REST OF EUROPE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

 

 

 

MARKET OUTLOOK

 

Triton Market Research’s report denotes that the nasal spray market in Europe is anticipated to grow at a compound annual growth rate of 8.35% during 2021-2028. Italy, Germany, Russia, Spain, the United Kingdom, France, and Rest of Europe form the market in this region.

In France, chronic bronchitis is a major health concern among the adult population. Moreover, the growing air pollution has increased the risks of lung cancer, chronic obstructive pulmonary disorder, and emphysema. Other than this, the rise in the elderly population has increased nasal allergies and respiratory diseases significantly in the past few years. Additionally, the elderly population grew by approximately 5.9% in 2020. Hence, the growing nasal allergies and growing elderly population have enhanced the demand for nasal sprays across the country, which is ultimately driving the growth of the nasal spray market.

According to the National Center for Biotechnology Information, the occurrence of chronic obstructive pulmonary diseases has increased significantly in Spain. Moreover, it is expected to affect more than 10% of the adult population in the next few years. In addition to this, a significant amount of the population suffers from hay fever in the country. This growth in respiratory conditions has enhanced the demand for nasal sprays across the country, thereby contributing to the overall development of the nasal spray market within Spain.

 

 

COMPETITIVE OUTLOOK

 

Major firms in the nasal spray market comprise Novartis International AG, Sun Pharmaceuticals Industries Ltd, GlaxoSmithKline, Allergan, Catalent Inc, Viatris, and Cipla Limited.

 

 

Get more insights into the Europe Nasal Spray Market:

 

https://www.tritonmarketresearch.com/reports/europe-nasal-spray-market

 

 

SEGMENTATION

 

1.     AKORN

2.     ALLERGAN

3.     APOTEX INC

4.     BHARAT BIOTECH

5.     CATALENT INC

6.     CIPLA LIMITED

7.     GLAXOSMITHKLINE

8.     JOHNSON AND JOHNSON

9.     NOVARTIS INTERNATIONAL AG

10. PFIZER INC

11. PROCTOR AND GAMBLE CO

12. SANOTIZE RESEARCH AND DEVELOPMENT

13. SUN PHARMACEUTICALS INDUSTRIES LTD

14. TEVA PHARMACEUTICAL INDUSTRIES LTD

15. VIATRIS